Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Wier

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Contributions to Gynecology and Obstetrics|January 1, 1985
Human placenta in vitro: characterization during 12 h of dual perfusionR K Miller, P J Wier, D Maulik, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 1, 1997
Effect of prazosin on sperm transport in male ratsH M Solomon, P J Wier, D L Ippolito, et al.
Human & Experimental Toxicology|December 3, 2002
Practical aspects of including functional endpoints in developmental toxicity studies. Case study: immune function in HuCD4 transgenic mice exposed to anti-CD4 MAb in uteroD J Herzyk, P J Bugelski, T K Hart, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1989
Evaluation of the teratogenic potential of octyl acetate in ratsW C Daughtrey, P J Wier, K A Traul, et al.
Teratology|February 8, 2000
Benzofuranyl ureas with potent cardiovascular teratogenicity in ratsH M Solomon, P J Wier, C M Johnson, et al.
Environmental Health Perspectives|July 28, 1999
Quantitative mechanistically based dose-response modeling with endocrine-active compoundsM E Andersen, R B Conolly, E M Faustman, et al.
Teratology|March 1, 1997
Spontaneous and induced alterations in the cardiac membranous ventricular septum of fetal, weanling, and adult ratsH M Solomon, P J Wier, C J Fish, et al.
Human & Experimental Toxicology|August 3, 2000
Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studiesP J Bugelski, D J Herzyk, S Rehm, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Contributions to Gynecology and Obstetrics|January 1, 1985
Human placenta in vitro: characterization during 12 h of dual perfusionR K Miller, P J Wier, D Maulik, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 1, 1997
Effect of prazosin on sperm transport in male ratsH M Solomon, P J Wier, D L Ippolito, et al.
Human & Experimental Toxicology|December 3, 2002
Practical aspects of including functional endpoints in developmental toxicity studies. Case study: immune function in HuCD4 transgenic mice exposed to anti-CD4 MAb in uteroD J Herzyk, P J Bugelski, T K Hart, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1989
Evaluation of the teratogenic potential of octyl acetate in ratsW C Daughtrey, P J Wier, K A Traul, et al.
Teratology|February 8, 2000
Benzofuranyl ureas with potent cardiovascular teratogenicity in ratsH M Solomon, P J Wier, C M Johnson, et al.
Environmental Health Perspectives|July 28, 1999
Quantitative mechanistically based dose-response modeling with endocrine-active compoundsM E Andersen, R B Conolly, E M Faustman, et al.
Teratology|March 1, 1997
Spontaneous and induced alterations in the cardiac membranous ventricular septum of fetal, weanling, and adult ratsH M Solomon, P J Wier, C J Fish, et al.
Human & Experimental Toxicology|August 3, 2000
Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studiesP J Bugelski, D J Herzyk, S Rehm, et al.
Pageof 2